Regis Healthcare Gelecekteki Büyüme

Future kriter kontrolleri 5/6

Regis Healthcare kazanç ve gelirin sırasıyla yıllık 30.9% ve 8.1% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 31.8% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 410.2% olacağı tahmin edilmektedir.

Anahtar bilgiler

30.9%

Kazanç büyüme oranı

31.8%

EPS büyüme oranı

Healthcare kazanç büyümesi	28.9%
Gelir büyüme oranı	8.1%
Gelecekteki özkaynak getirisi	410.2%
Analist kapsamı	Good
Son güncelleme	25 Feb 2025

Gelecekteki son büyüme güncellemeleri

Recent updates

Investor Optimism Abounds Regis Healthcare Limited (ASX:REG) But Growth Is Lacking

Dec 20

Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Sep 12

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

May 02

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Mar 21

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

Feb 28

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Oct 18

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Aug 26

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

Feb 25

Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

May 27

Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

May 09

Should You Be Excited About Regis Healthcare Limited's (ASX:REG) 23% Return On Equity?

Aug 10

At AU$1.32, Is Regis Healthcare Limited (ASX:REG) Worth Looking At Closely?

Aug 10

Reflecting on Regis Healthcare's (ASX:REG) Share Price Returns Over The Last Five Years

Jul 14

Is Regis Healthcare Limited (ASX:REG) An Attractive Dividend Stock?

Jul 02

Kazanç ve Gelir Büyüme Tahminleri

ASX:REG - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (AUD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2027	1,353	83	168	244	7
6/30/2026	1,271	65	127	214	7
6/30/2025	1,177	47	10	244	7
12/31/2024	1,098	15	242	309	N/A
9/30/2024	1,056	-3	214	281	N/A
6/30/2024	1,014	-21	187	252	N/A
3/31/2024	947	-18	159	224	N/A
12/31/2023	880	-15	132	195	N/A
9/30/2023	830	-22	93	150	N/A
6/30/2023	781	-28	54	105	N/A
3/31/2023	761	-45	34	78	N/A
12/31/2022	741	-61	14	50	N/A
9/30/2022	733	-50	41	82	N/A
6/30/2022	725	-39	68	115	N/A
3/31/2022	719	-16	N/A	N/A	N/A
12/31/2021	713	8	104	143	N/A
9/30/2021	707	14	96	124	N/A
6/30/2021	701	20	88	105	N/A
3/31/2021	700	8	N/A	N/A	N/A
12/31/2020	699	-4	86	105	N/A
9/30/2020	688	-2	87	116	N/A
6/30/2020	678	-1	88	127	N/A
3/31/2020	655	21	111	156	N/A
12/31/2019	661	39	134	186	N/A
9/30/2019	654	45	144	203	N/A
6/30/2019	647	51	155	220	N/A
3/31/2019	632	51	101	204	N/A
12/31/2018	617	50	47	188	N/A
9/30/2018	606	52	N/A	161	N/A
6/30/2018	594	54	N/A	134	N/A
3/31/2018	586	56	N/A	129	N/A
12/31/2017	577	57	N/A	124	N/A
9/30/2017	571	59	N/A	138	N/A
6/30/2017	565	61	N/A	151	N/A
3/31/2017	547	55	N/A	151	N/A
12/31/2016	529	50	N/A	152	N/A
9/30/2016	505	48	N/A	143	N/A
6/30/2016	481	47	N/A	134	N/A
3/31/2016	468	59	N/A	146	N/A
12/31/2015	455	71	N/A	159	N/A
9/30/2015	446	64	N/A	143	N/A
6/30/2015	438	58	N/A	127	N/A
3/31/2015	433	28	N/A	119	N/A
12/31/2014	428	-1	N/A	110	N/A
9/30/2014	419	0	N/A	122	N/A
6/30/2014	410	1	N/A	135	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: REG 'nin tahmini kazanç büyümesi (yıllık 30.9% ) tasarruf oranının ( 2.7% ) üzerindedir.

Kazançlar ve Piyasa: REG şirketinin kazançlarının (yıllık 30.9% ) Australian pazarından (yıllık 12.2% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: REG şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: REG şirketinin gelirinin (yıllık 8.1% ) Australian pazarından (yıllık 6% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: REG şirketinin gelirinin (yıllık 8.1% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: REG 'nin Özsermaye Getirisi'nin 3 yıl içinde çok yüksek olması tahmin ediliyor ( 410.2 %).

Büyüyen şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/03/17 16:42
Gün Sonu Hisse Fiyatı	2025/03/17 00:00
Kazançlar	2024/12/31
Yıllık Kazançlar	2024/06/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Regis Healthcare Limited 17 Bu analistlerden 7, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
William Dunlop	BofA Global Research
David Stanton	CLSA
David Low	Deutsche Bank

Regis Healthcare Gelecekteki Büyüme

Future kriter kontrolleri 5/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Price target increased by 7.1% to AU$7.31

Price target increased by 7.5% to AU$4.74

Price target increased by 8.5% to AU$4.37

Price target increased by 7.3% to AU$3.77

Price target increased by 9.0% to AU$3.52

Price target increased by 7.4% to AU$3.43

Recent updates

First half dividend increased to AU$0.081

First half 2025 earnings: EPS and revenues exceed analyst expectations

Regis Healthcare Limited Resolves to Pay an Interim Dividend for the Half-Year Ended 31 December 2024, Payable on 10 April 2025

Regis Healthcare Limited to Report First Half, 2025 Results on Feb 24, 2025

Price target increased by 7.1% to AU$7.31

Investor Optimism Abounds Regis Healthcare Limited (ASX:REG) But Growth Is Lacking

Regis Healthcare Limited (ASX:REG) acquired Two residential aged care homes in Capel Sound and Mornington from Ti Tree Operations Pty Ltd.

Regis Healthcare Limited Announces Retirement of Bryan Dorman as Non-Executive Director, Effective 26 November 2024

Regis Healthcare Limited, Annual General Meeting, Nov 26, 2024

Regis Healthcare Limited (ASX:REG) agreed to acquire Two residential aged care homes in Capel Sound and Mornington from Ti Tree Operations Pty Ltd for AUD 35.5 million.

Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Final dividend of AU$0.066 announced

Price target increased by 7.5% to AU$4.74

Full year 2024 earnings: Revenues exceed analyst expectations

Regis Healthcare Limited to Report Second Half, 2024 Results on Aug 26, 2024

Price target increased by 8.5% to AU$4.37

Non-Executive Director recently sold AU$68m worth of stock

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Upcoming dividend of AU$0.063 per share

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

First half dividend increased to AU$0.063

Price target increased by 7.3% to AU$3.77

Price target increased by 9.0% to AU$3.52

Price target increased by 7.4% to AU$3.43

Regis Healthcare Limited to Report First Half, 2024 Results on Feb 26, 2024

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited (ASX:REG) agreed to acquire Cpsm Pty Ltd for AUD 74.2 million.

Price target increased by 11% to AU$3.07

Price target increased by 7.0% to AU$2.77

Consensus EPS estimates upgraded to AU$0.083 loss

Price target increased by 8.7% to AU$2.74

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Price target increased by 8.8% to AU$2.59

Upcoming dividend of AU$0.075 per share at 3.8% yield

Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year

Consensus EPS estimates fall by 14%, revenue upgraded

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on September 27, 2023

Regis Healthcare Limited Announces the Resignation of Rebecca Dean as Company Secretary

Regis Healthcare Limited, Annual General Meeting, Oct 24, 2023

Regis Healthcare Limited to Report Fiscal Year 2023 Results on Aug 25, 2023

Price target increased by 7.6% to AU$2.33

Consensus EPS estimates fall by 18%

Upcoming dividend of AU$0.02 per share at 3.7% yield

Regis Healthcare (ASX:REG) Is Paying Out Less In Dividends Than Last Year

First half 2023 earnings released: AU$0.086 loss per share (vs AU$0.012 loss in 1H 2022)

Regis Healthcare Limited to Report First Half, 2023 Results on Feb 24, 2023

Consensus forecasts updated

Is Regis Healthcare (ASX:REG) Using Debt Sensibly?

Upcoming dividend of AU$0.023 per share

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Announces Fiscal Year 2022 Final Dividend, Payable on September 30, 2022

Regis Healthcare Limited, Annual General Meeting, Oct 25, 2022

Consensus forecasts updated

Consensus forecasts updated

Regis Healthcare Limited to Report Fiscal Year 2022 Results on Aug 24, 2022

Now 21% undervalued

Consensus forecasts updated

Upcoming dividend of AU$0.035 per share

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Declares Franked Ordinary Dividend for the Six Months Ended December 31, 2021, Payable on April 8, 2022

Upcoming dividend of AU$0.046 per share

Full year 2021 earnings released

Price target increased to AU$2.49

Consensus forecasts updated